Overview Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder Status: Recruiting Trial end date: 2024-12-31 Target enrollment: Participant gender: Summary To study the clinical efficacy and safety of autologous umbilical cord blood transfusion in the treatment of autism spectrum disorder. Phase: Phase 1 Details Lead Sponsor: Guangdong Women and Children Hospital